Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...

The deal extends an agreement to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Under the expanded collaboration, Valo's Opal Computational Platform will be integrated with Novo Nordisk's expertise in cardiometabolic diseases, deriving insights from real-world patient data, ...